cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.20317672.v1
title: Additional file 5 of Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning

description: Additional file 5: Table S4. Individual values for figures where the number of independent replicates is less than 6.
DOI: 10.6084/m9.figshare.20317675
title: Additional file 6 of Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning

description: Additional file 6: Table S5. Degrons in driver regions, proteins rich in degron mutations, and novel potential driver mutations in Degpred degrons.
DOI: 10.6084/m9.figshare.20317675.v1
title: Additional file 6 of Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning

description: Additional file 6: Table S5. Degrons in driver regions, proteins rich in degron mutations, and novel potential driver mutations in Degpred degrons.
DOI: 10.6084/m9.figshare.20317678
title: Additional file 7 of Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning

description: Additional file 7: Table S6. Enriched function groups of short-lived proteins.
DOI: 10.6084/m9.figshare.20317678.v1
title: Additional file 7 of Systematic prediction of degrons and E3 ubiquitin ligase binding via deep learning

description: Additional file 7: Table S6. Enriched function groups of short-lived proteins.
DOI: 10.48597/k4j6-gj9w
title: Sum_ammonia_and_ammonium at Anholt

description: Measurement of Sum_ammonia_and_ammonium at Anholt
DOI: 10.48597/kmfw-h9q7
title: VOC (carbonyls) at Peyrusse Vieille

description: Measurement of VOC (carbonyls) at Peyrusse Vieille
DOI: 10.48597/kr75-ugpy
title: Delta_D_methane and methane at Zeppelin mountain (Ny-Ålesund)

description: Measurement of Delta_D_methane and methane at Zeppelin mountain (Ny-Ålesund)
DOI: 10.48597/mvfw-9xqs
title: Ozone at Birmingham Air Quality Site (BAQS)

description: Measurement of Ozone at Birmingham Air Quality Site (BAQS)
DOI: 10.48597/mxxx-79mc
title: 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Herstal

description: Measurement of 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Herstal
DOI: 10.48597/n7vx-nk4z
title: 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Namur

description: Measurement of 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Namur
DOI: 10.48597/ng37-t4p5
title: 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Mons

description: Measurement of 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Mons
DOI: 10.48597/qgd6-8d9a
title: Aerosol_optical_depth at Wagga Wagga

description: Measurement of Aerosol_optical_depth at Wagga Wagga
DOI: 10.48597/qt6j-9yzq
title: Ozone at Villeneuve d'Ascq

description: Measurement of Ozone at Villeneuve d'Ascq
DOI: 10.48597/u2ne-zc3k
title: Ozone at Villeneuve d'Ascq

description: Measurement of Ozone at Villeneuve d'Ascq
DOI: 10.48597/vb9w-s5n8
title: Delta_D_methane and methane at Zeppelin mountain (Ny-Ålesund)

description: Measurement of Delta_D_methane and methane at Zeppelin mountain (Ny-Ålesund)
DOI: 10.48597/w794-yp8v
title: 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Charleroi-Mayence

description: Measurement of 1-2-dichloroethane, greenhouse gases (other halogenated) and VOC (hydrocarbons) at Charleroi-Mayence
DOI: 10.48597/w7vy-uze5
title: Nitrogen_dioxide at Villeneuve d'Ascq

description: Measurement of Nitrogen_dioxide at Villeneuve d'Ascq
DOI: 10.48597/yz4e-6kfa
title: OC/EC at Barcelona (Palau Reial)

description: Measurement of OC/EC at Barcelona (Palau Reial)
DOI: 10.6084/m9.figshare.12570113
title: High resolution QTL mapping for identification of candidate genes associated with metribuzin tolerance in hexaploid wheat (Triticum aestivum L.): Supplementary Tables (Table S1, Table S2 and Table S3)

description: Table S1 The phenotypic data used for QTL mappingTable S2 The genotypic data used for QTL mappingTable S3 DArTseq of 137 RILs & parents
DOI: 10.6084/m9.figshare.23055892
title: Safety of direct oral anticoagulants in patients with liver disease: a systematic review and meta-analysis

description: Direct oral anticoagulants (DOACs), such as apixaban, edoxaban, rivaroxaban, or dabigatran, are an effective treatment for atrial fibrillation (AF) and deep venous thromboembolism. We hope to evaluate the safety of DOACs versus warfarin/low molecular weight heparin (LMWH) in improving bleeding events in patients with different severity of the liver disease. We systematically searched the Cochrane Library, PubMed, and Embase databases for studies reporting the effects of DOACs in patients with liver cirrhosis. A random-effects model or fixed-effects model was selected to pool risk ratios (RR) and 95% confidence intervals (CI). A total of 18 studies involving 41,447 participants was included in this meta-analysis. Compare with warfarin/ LMWH, the use of DOACs significantly reduced the incidence of all bleeding (RR: 0.76; 95%CI: 0.66 to 0.87), major bleeding (RR: 0.51; 95%CI: 0.28 to 0.91), intracranial hemorrhage (RR: 0.50; 95%CI: 0.31 to 0.81), and gastrointestinal bleeding (RR: 0.76, 95% CI: 0.60 to 0.97), and all-cause death in patients with liver disease (RR: 0.77; 95%CI: 0.62 to 0.95). Similar results were observed in atrial fibrillation patients with liver disease and cirrhosis subgroups. Furthermore, the pooled estimates of the Child-Turcotte-Pugh (CTP) class indicated that DOACs reduced the incidence of all bleeding (RR: 0.61; 95%CI: 0.45 to 0.82), gastrointestinal bleeding (RR 0.55; 95%CI: 0.37 to 0.83), and all-cause death (RR: 0.62; 95%CI: 0.49 to 0.79) in patients with mild to moderate cirrhosis. Our study demonstrates that DOACs significantly reduce the risk of bleeding in patients with liver disease compared with warfarin/LMWH.
DOI: 10.6084/m9.figshare.23055892.v1
title: Safety of direct oral anticoagulants in patients with liver disease: a systematic review and meta-analysis

description: Direct oral anticoagulants (DOACs), such as apixaban, edoxaban, rivaroxaban, or dabigatran, are an effective treatment for atrial fibrillation (AF) and deep venous thromboembolism. We hope to evaluate the safety of DOACs versus warfarin/low molecular weight heparin (LMWH) in improving bleeding events in patients with different severity of the liver disease. We systematically searched the Cochrane Library, PubMed, and Embase databases for studies reporting the effects of DOACs in patients with liver cirrhosis. A random-effects model or fixed-effects model was selected to pool risk ratios (RR) and 95% confidence intervals (CI). A total of 18 studies involving 41,447 participants was included in this meta-analysis. Compare with warfarin/ LMWH, the use of DOACs significantly reduced the incidence of all bleeding (RR: 0.76; 95%CI: 0.66 to 0.87), major bleeding (RR: 0.51; 95%CI: 0.28 to 0.91), intracranial hemorrhage (RR: 0.50; 95%CI: 0.31 to 0.81), and gastrointestinal bleeding (RR: 0.76, 95% CI: 0.60 to 0.97), and all-cause death in patients with liver disease (RR: 0.77; 95%CI: 0.62 to 0.95). Similar results were observed in atrial fibrillation patients with liver disease and cirrhosis subgroups. Furthermore, the pooled estimates of the Child-Turcotte-Pugh (CTP) class indicated that DOACs reduced the incidence of all bleeding (RR: 0.61; 95%CI: 0.45 to 0.82), gastrointestinal bleeding (RR 0.55; 95%CI: 0.37 to 0.83), and all-cause death (RR: 0.62; 95%CI: 0.49 to 0.79) in patients with mild to moderate cirrhosis. Our study demonstrates that DOACs significantly reduce the risk of bleeding in patients with liver disease compared with warfarin/LMWH.
DOI: 10.6084/m9.figshare.24104508
title: DRS & EDS Dataset in Supporting Information Jiao JW et al., 2023.xlsx

description: The dataset set includes two worksheets in the EXCEL. The first worksheet documents the EDS data in the SEM observations and diffuse reflectance spectroscopy data. The second one documents the DRS data including the band intensity of goethite and hematite and the hematite/goethite ratio.
DOI: 10.6084/m9.figshare.11521620
title: MOESM1 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 1: Table S1. Summary of the basic information of HF patients and normal controls included in the study.
DOI: 10.6084/m9.figshare.11521620.v1
title: MOESM1 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 1: Table S1. Summary of the basic information of HF patients and normal controls included in the study.
DOI: 10.6084/m9.figshare.11521623
title: MOESM2 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 2: Table S2. The RNA-seq statistics and alignment information for each sample.
DOI: 10.6084/m9.figshare.11521623.v1
title: MOESM2 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 2: Table S2. The RNA-seq statistics and alignment information for each sample.
DOI: 10.6084/m9.figshare.11521629
title: MOESM3 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 3: Table S3. Functional enrichment analysis of differentially expressed mRNAs by online tool WebGestalt.
DOI: 10.6084/m9.figshare.11521629.v1
title: MOESM3 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 3: Table S3. Functional enrichment analysis of differentially expressed mRNAs by online tool WebGestalt.
DOI: 10.6084/m9.figshare.11521641
title: MOESM4 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 4: Table S4. The detailed information of differentially expressed lncRNAs.
DOI: 10.6084/m9.figshare.11521641.v1
title: MOESM4 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 4: Table S4. The detailed information of differentially expressed lncRNAs.
DOI: 10.6084/m9.figshare.11521647
title: MOESM5 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 5: Table S5. Functional enrichment analysis of differentially expressed microRNAs by using tool miEAA.
DOI: 10.6084/m9.figshare.11521647.v1
title: MOESM5 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 5: Table S5. Functional enrichment analysis of differentially expressed microRNAs by using tool miEAA.
DOI: 10.6084/m9.figshare.7851635
title: Considering Over-Dispersion in the Sample Size Calculation for Clinical Trials With Repeated Count Measurements

description: Over-dispersed count variables are frequently encountered in biomedical research. Despite extensive research in analytical methods, addressing over-dispersion in the design of clinical trials has received much less attention. In this study, we propose to directly incorporate over-dispersion into sample size calculation for clinical trials where a count outcome is repeatedly measured on each subject. The proposed method is applicable to the comparison of slopes as well as time-averaged responses. It is easy to compute and flexible enough to account for unbalanced randomization, arbitrary missing patterns, and different correlation structures. We show that sample size requirement is proportional to over-dispersion, which highlights the danger of ignoring over-dispersion in experimental design. Simulation results demonstrate that the proposed sample size calculation methods maintain the nominal levels of power and Type I error over a wide range of scenarios. Application example to an epileptic trial is presented. Supplementary materials for this article are available online.
DOI: 10.6084/m9.figshare.7851635.v2
title: Considering Over-Dispersion in the Sample Size Calculation for Clinical Trials With Repeated Count Measurements

description: Over-dispersed count variables are frequently encountered in biomedical research. Despite extensive research in analytical methods, addressing over-dispersion in the design of clinical trials has received much less attention. In this study, we propose to directly incorporate over-dispersion into sample size calculation for clinical trials where a count outcome is repeatedly measured on each subject. The proposed method is applicable to the comparison of slopes as well as time-averaged responses. It is easy to compute and flexible enough to account for unbalanced randomization, arbitrary missing patterns, and different correlation structures. We show that sample size requirement is proportional to over-dispersion, which highlights the danger of ignoring over-dispersion in experimental design. Simulation results demonstrate that the proposed sample size calculation methods maintain the nominal levels of power and Type I error over a wide range of scenarios. Application example to an epileptic trial is presented. Supplementary materials for this article are available online.
DOI: 10.6084/m9.figshare.7851635.v1
title: Considering Over-dispersion in the Sample Size Calculation for Clinical Trials with Repeated Count Measurements

description: Over-dispersed count variables are frequently encountered in biomedical research. Despite extensive research in analytical methods, addressing over-dispersion in the design of clinical trials has received much less attention. In this study we propose to directly incorporate over-dispersion into sample size calculation for clinical trials where a count outcome is repeatedly measured on each subject. The proposed method is applicable to the comparison of slopes as well as time-averaged responses. It is easy to compute and flexible enough to account for unbalanced randomization, arbitrary missing patterns, and different correlation structures. We show that sample size requirement is proportional to over-dispersion, which highlights the danger of ignoring over-dispersion in experimental design. Simulation results demonstrate that the proposed sample size calculation methods maintain the nominal levels of power and type I error over a wide range of scenarios. Application example to an epileptic trial is presented.
DOI: 10.6084/m9.figshare.11521653
title: MOESM6 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 6: Table S6. Fibrosis percentage and survival data for each heart failure sample.
DOI: 10.6084/m9.figshare.11521653.v1
title: MOESM6 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 6: Table S6. Fibrosis percentage and survival data for each heart failure sample.
DOI: 10.6084/m9.figshare.11521659
title: MOESM7 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 7: Table S7. Fibrosis related genes identified by lasso regression analysis.
DOI: 10.6084/m9.figshare.11521662
title: MOESM8 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 8: Table S8. Evaluation of survival (years) by using plasma COL1A1 level of HF patients.
DOI: 10.6084/m9.figshare.11521662.v1
title: MOESM8 of Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression

description: Additional file 8: Table S8. Evaluation of survival (years) by using plasma COL1A1 level of HF patients.
DOI: 10.6084/m9.figshare.12570248
title: Data for "Complexity-based matching between image resolution and map scale for multi-scale image-map generation"

description: An image-map is a compromise of an image
and a map. The quality of such maps is
affected by a number of factors, such as (a) the matching between the features
on images and the graphic symbols from maps, (b) the
complexity of background images, and (c) the representation of graphic and text
symbols on the images. This project
deals with the first issue. The current solution is
that the accuracy of images should satisfy the accuracy standard of maps. However, images with
different resolutions can satisfy the standard for a specific map scale. This may lead to such a situation that the levels
of detail (LoD) in images may not match the complexity of map features although
the planimetric accuracy is matched. To solve
this problem, we developed a complexity-based matching between the image
resolution and map scale. More
precisely, the matching is based on the complexity of line features. Experimental evaluations were conducted in
fifteen representative areas in Hong Kong, by using maps at seven scales and
eight image resolutions. Results show
that this complexity-based method is capable of obtaining good matching between
image resolution and map scale, in terms of both accuracy and users'
preference.
DOI: 10.6084/m9.figshare.10473113
title: Differential alternative splicing events selected for RT-PCR validation

description: The data cover 11 DAS events in Mecp2 knockout mice for RT-PCR validations. Each event has a UCSC genome browser track, a representative image from the agarose gel electrophoresis, and a bar graph showing the PSI values for samples.
DOI: 10.6084/m9.figshare.10473113.v1
title: Differential alternative splicing events selected for RT-PCR validation

description: The data cover 11 DAS events in Mecp2 knockout mice for RT-PCR validations. Each event has a UCSC genome browser track, a representative image from the agarose gel electrophoresis, and a bar graph showing the PSI values for samples.
DOI: 10.6084/m9.figshare.10473116
title: Primer sequences for the RT-PCR validations

description: Used primer sequences for the RT-PCR validations.
DOI: 10.6084/m9.figshare.10473116.v1
title: Primer sequences for the RT-PCR validations

description: Used primer sequences for the RT-PCR validations.
DOI: 10.6084/m9.figshare.12046008
title: Exosomes derived from GIT1-overexpressing bone marrow mesenchymal stem cells promote traumatic spinal cord injury recovery in a rat model

description: This study aims to explore the effects of exosomes derived from G protein-coupled receptor kinase 2 interacting protein 1 (GIT1)-overexpressing bone marrow mesenchymal stem cell (GIT1-BMSC-Exos) on the treatment of traumatic spinal cord injury (SCI) in a rat model. All the rats underwent a T10 laminectomy. A weight-drop impact was performed using a 10-g rod from a height of 12.5 mm except the sham group. Rats with SCI were distributed into three groups randomly and then treated with tail vein injection of GIT1-BMSCs-Exos, BMSCs-Exos and PBS, respectively. The effects of GIT1-Exos on glutamate (GLU)-induced apoptosis <i>in vitro</i> were also evaluated by TUNEL staining. The results showed that rats treated with GIT1-BMSCs-Exos had better functional behavioral recovery than those treated with PBS or BMSCs-Exos only. The overexpression of GIT1 in BMSCs-Exos not only restrained glial scar formation and neuroinflammation after SCI, but also attenuated apoptosis and promoted axonal regeneration in the injured lesion area. Neuronal cell death induced by GLU was controlled remarkably <i>in vitro</i> as well. In conclusion, our study suggested that the application of GIT1-BMSCs-Exos may provide a novel avenue for traumatic SCI treatment.
DOI: 10.6084/m9.figshare.12046008.v1
title: Exosomes derived from GIT1-overexpressing bone marrow mesenchymal stem cells promote traumatic spinal cord injury recovery in a rat model

description: This study aims to explore the effects of exosomes derived from G protein-coupled receptor kinase 2 interacting protein 1 (GIT1)-overexpressing bone marrow mesenchymal stem cell (GIT1-BMSC-Exos) on the treatment of traumatic spinal cord injury (SCI) in a rat model. All the rats underwent a T10 laminectomy. A weight-drop impact was performed using a 10-g rod from a height of 12.5 mm except the sham group. Rats with SCI were distributed into three groups randomly and then treated with tail vein injection of GIT1-BMSCs-Exos, BMSCs-Exos and PBS, respectively. The effects of GIT1-Exos on glutamate (GLU)-induced apoptosis <i>in vitro</i> were also evaluated by TUNEL staining. The results showed that rats treated with GIT1-BMSCs-Exos had better functional behavioral recovery than those treated with PBS or BMSCs-Exos only. The overexpression of GIT1 in BMSCs-Exos not only restrained glial scar formation and neuroinflammation after SCI, but also attenuated apoptosis and promoted axonal regeneration in the injured lesion area. Neuronal cell death induced by GLU was controlled remarkably <i>in vitro</i> as well. In conclusion, our study suggested that the application of GIT1-BMSCs-Exos may provide a novel avenue for traumatic SCI treatment.
DOI: 10.48597/zr7a-gkns
title: Measurement of Precipitation_amount at Pallas (Matorova)

description: Measurement of Precipitation_amount at Pallas (Matorova)
DOI: 10.48597/2en4-ep7g
title: Measurement of Particle_number_size_distribution at Preila

description: Measurement of Particle_number_size_distribution at Preila
DOI: 10.48597/35fs-489v
title: Measurement of Aerosol light scattering at Southern Great Plains E13

description: Measurement of Aerosol light scattering at Southern Great Plains E13
DOI: 10.48597/3h6v-gb7n
title: Measurement of Pressure at Southern Great Plains E13

description: Measurement of Pressure at Southern Great Plains E13
DOI: 10.48597/3rxp-jesf
title: Measurement of Aerosol light scattering at Bukit Kototabang

description: Measurement of Aerosol light scattering at Bukit Kototabang
DOI: 10.48597/3vxt-6h7j
title: Measurement of Relative_humidity at Southern Great Plains E13

description: Measurement of Relative_humidity at Southern Great Plains E13
DOI: 10.48597/3znp-h2yx
title: Measurement of Pressure at Southern Great Plains E13

description: Measurement of Pressure at Southern Great Plains E13
DOI: 10.48597/42k2-db94
title: Measurement of Aerosol light scattering at Southern Great Plains E13

description: Measurement of Aerosol light scattering at Southern Great Plains E13
DOI: 10.15468/dl.kba5ay
title: Occurrence Download

description: A dataset containing 101 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Ilex krugiana Loes. ex Urb."
 ]
}

 The dataset includes 101 records from 7 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0040708-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.2zgj75
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is South America",
 "Country is Colombia",
 "Locality is Támesis"
 ]
}

 The dataset includes 4 records from 4 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0254696-200613084148143/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.